GILD’s Sovaldi + GS-5816 combination is essentially equivalent to Sovaldi + Ledipasvir except that it works in genotype-3, where Ledipasvir isn’t active.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.